Innoviva (INVA) EBITDA Margin Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -781.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -781.00 |
| Dec 31, 2025 | -42,065.00 |
| Sep 30, 2025 | -1,623.00 |
| Jun 30, 2025 | -613.00 |
| Mar 31, 2025 | 110,554.00 |
| Dec 31, 2024 | -42,286.00 |
| Sep 30, 2024 | -7,949.00 |
| Jun 30, 2024 | 103,729.00 |
| Mar 31, 2024 | 36,658.00 |
| Dec 31, 2023 | 55,219.00 |
| Sep 30, 2023 | 12,741.00 |
| Jun 30, 2023 | -49,291.00 |
| Mar 31, 2023 | -71,543.00 |
| Dec 31, 2022 | -37,116.00 |
| Sep 30, 2022 | -9,623.00 |
| Jun 30, 2022 | -875,506.00 |
| Mar 31, 2022 | -20,010.00 |
| Dec 31, 2021 | 66,883.00 |
| Sep 30, 2021 | 143.00 |
| Jun 30, 2021 | 816,941.00 |
| Mar 31, 2021 | -60,659.00 |
| Dec 31, 2020 | -137,729.00 |
| Sep 30, 2020 | 274.00 |
| Jun 30, 2020 | 278.00 |
| Mar 31, 2020 | 221.00 |
| Dec 31, 2019 | 23.00 |
| Sep 30, 2019 | -103.00 |
| Jun 30, 2019 | -21.00 |
| Mar 31, 2019 | 1,684.00 |
| Dec 31, 2018 | 117.00 |
| Sep 30, 2018 | 1,121.00 |
| Jun 30, 2018 | 1,175.00 |
| Mar 31, 2018 | 523.00 |
| Dec 31, 2017 | 917.00 |
| Sep 30, 2017 | -154.00 |
| Jun 30, 2017 | 198.00 |
| Mar 31, 2017 | -5.00 |
| Dec 31, 2016 | 1,063.00 |
| Sep 30, 2016 | 2,163.00 |
| Jun 30, 2016 | 3,175.00 |
| Mar 31, 2016 | 6,171.00 |
| Dec 31, 2015 | 7,394.00 |
| Sep 30, 2015 | 101,734.00 |
| Jun 30, 2015 | 109,655.00 |
| Mar 31, 2015 | 189,837.00 |
| Dec 31, 2014 | 50,532.00 |
| Sep 30, 2014 | 90,195.00 |
| Jun 30, 2014 | -52,682.00 |
| Mar 31, 2014 | 63,793.00 |
| Dec 31, 2013 | -53,741.00 |
| Sep 30, 2013 | 47,506.00 |
| Jun 30, 2013 | 630,594.00 |
| Mar 31, 2013 | -259,389.00 |
| Dec 31, 2012 | 69,734.00 |
| Sep 30, 2012 | -187,809.00 |
| Jun 30, 2012 | -645,745.00 |
| Mar 31, 2012 | 40,487.00 |